134 related articles for article (PubMed ID: 31666416)
1. [Cytokine production by blood immune cells, tumor and its microenvironment, characteristic of extracellular matrix in patients with invasive ductal carcinoma of no special type].
Autenshlyus AI; Davletova KI; Studenikina AA; Mikhaylova ES; Varaksin NA; Zhurakovsky IP; Proskura AV; Sidorov SV; Lyakhovich VV
Biomed Khim; 2019 Aug; 65(5):424-431. PubMed ID: 31666416
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases].
Autenshlyus AI; Studenikina AA; Bernado AV; Mikhailova ES; Proskura AV; Sidorov SV; Varaksin NA; Lyakhovich VV
Biomed Khim; 2019 Aug; 65(5):418-423. PubMed ID: 31666415
[TBL] [Abstract][Full Text] [Related]
3. [Influence of the HLDF differentiation factor on the production of cytokines by bio-tissues of breast tissue in its non-malignant diseases and in invasive carcinoma of a non-specific type].
Autenshlyus AI; Studenikina AA; Mikhaylova YS; Proskura AV; Varaksin NA; Sidorov SV; Bogachuk AP; Lipkin VM; Lyakhovich VV
Biomed Khim; 2020 Nov; 66(6):485-493. PubMed ID: 33372907
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production in mammary adenocarcinoma and its microenvironmental cells in patients with or without metastases in regional lymph nodes.
Autenshlyus A; Arkhipov S; Mikhailova E; Marinkin I; Arkhipova V; Mogilnaya E; Varaksin N; Rukavishnikov M
Int J Immunopathol Pharmacol; 2017 Sep; 30(3):308-314. PubMed ID: 28745079
[TBL] [Abstract][Full Text] [Related]
5. Effects of polyclonal activators on cell differentiation and cytokine production of cultured invasive breast carcinoma of no special type, their association with tumour histopathological parameters and lymph node metastasis.
Autenshlyus A; Arkhipov S; Mikhailova E; Marinkin I; Varaksin N; Vavilin V; Lyakhovich V
Int J Immunopathol Pharmacol; 2020; 34():2058738420950580. PubMed ID: 33100082
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between supernatant cytokines and expression of markers of epitelial-mesenchymal transition of invasive breast carcinoma of non-specific lymphynosis type].
Autenshlyus AI; Studenikina AA; Arkhipov SA; Davletova KI; Zhurakovsky IP; Proskura AV; Varaksin NA; Lyakhovich VV
Biomed Khim; 2020 Jan; 66(1):83-88. PubMed ID: 32116230
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.
Autenshlyus AI; Arkhipov SA; Kunts TA; Marinkin IO; Mikhailova ES; Karpukhina XV; Varaksin NA
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):83-88. PubMed ID: 27903846
[TBL] [Abstract][Full Text] [Related]
8. Cytokines in various molecular subtypes of breast cancer.
Autenshlyus A; Davletova K; Varaksin N; Marinkin I; Lyakhovich V
Int J Immunopathol Pharmacol; 2021; 35():20587384211034089. PubMed ID: 34399595
[TBL] [Abstract][Full Text] [Related]
9. Influence of Internal and External Factors on the Production of Cytokines by Peripheral Blood Cells in Breast Cancer.
Autenshlyus AI; Davletova KI; Mikhaylova ES; Proskura AV; Varaksin NA; Bogachuk AP; Sidorov SV; Lyakhovich VV; Lipkin VM
Dokl Biochem Biophys; 2020 Jul; 493(1):178-180. PubMed ID: 32894459
[TBL] [Abstract][Full Text] [Related]
10. VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these malignant tumors.
Autenshlyus A; Arkhipov S; Mikhailova E; Arkhipova V; Varaksin N
Int J Immunopathol Pharmacol; 2018; 32():2058738418787990. PubMed ID: 29985074
[TBL] [Abstract][Full Text] [Related]
11. Analyzing the relationship between the cytokine profile of invasive breast carcinoma, its histopathological characteristics and metastasis to regional lymph nodes.
Autenshlyus A; Arkhipov S; Mikhaylova E; Marinkin I; Arkhipova V; Varaksin N; Vavilin V; Lyahovich V
Sci Rep; 2021 May; 11(1):11359. PubMed ID: 34059727
[TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.
Kuerer HM; Peoples GE; Sahin AA; Murray JL; Singletary SE; Castilleja A; Hunt KK; Gershenson DM; Ioannides CG
J Interferon Cytokine Res; 2002 May; 22(5):583-92. PubMed ID: 12060497
[TBL] [Abstract][Full Text] [Related]
13. Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells.
Kunts TA; Karpukhina KV; Mikhaylova ES; Marinkin IO; Varaksin NA; Autenshlyus AI; Lyakhovich VV
Dokl Biol Sci; 2016; 466():45-7. PubMed ID: 27021370
[TBL] [Abstract][Full Text] [Related]
14. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes.
Camp BJ; Dyhrman ST; Memoli VA; Mott LA; Barth RJ
Ann Surg Oncol; 1996 Mar; 3(2):176-84. PubMed ID: 8646519
[TBL] [Abstract][Full Text] [Related]
15. Cytokine pattern of the breast tumor supernatant.
Autenshlyus AI; Kunts TA; Karpukhina KV; Mikhaylova ES; Varaksin NA; Marinkin IO; Lyakhovich VV
Dokl Biol Sci; 2016 Sep; 470(1):247-248. PubMed ID: 27822759
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production by the tumor from patients with breast cancer in different age groups.
Kunts TA; Mikhaylova ES; Marinkin IO; Varaksin NA; Autenshlyus AI; Lyakhovich VV
Dokl Biol Sci; 2017 Jul; 475(1):172-174. PubMed ID: 28861874
[TBL] [Abstract][Full Text] [Related]
17. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
[TBL] [Abstract][Full Text] [Related]
18. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.
Danis VA; Millington M; Hyland VJ; Grennan D
Clin Exp Immunol; 1995 Feb; 99(2):303-10. PubMed ID: 7851026
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-1beta in human breast carcinoma.
Jin L; Yuan RQ; Fuchs A; Yao Y; Joseph A; Schwall R; Schnitt SJ; Guida A; Hastings HM; Andres J; Turkel G; Polverini PJ; Goldberg ID; Rosen EM
Cancer; 1997 Aug; 80(3):421-34. PubMed ID: 9241076
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor negative breast cancers exhibit high cytokine content.
Chavey C; Bibeau F; Gourgou-Bourgade S; Burlinchon S; Boissière F; Laune D; Roques S; Lazennec G
Breast Cancer Res; 2007; 9(1):R15. PubMed ID: 17261184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
